More guidence on Valproate

On the 9th February 2015, NHS England issued the attached communique to further reinforce the strengthened teratogenicity warnings concerning Valproate issued by the MHRA in November 2014. These are intended to be distributed to all professionals involved in the prescribing of Valproate, and may lead to further enquiries from our non specialist colleagues and patients.